aires

A specialty pharmaceutical and medical
device company focused on developing
and commercializing best in class products
to treat gastrointestinal diseases.

A specialty pharmaceutical and medical device company focused on developing and commercializing best in class products to treat gastrointestinal diseases.
Find out more

Aries Pharmaceuticals, Inc. Shares Positive Results for Clinical Study of Eleview™ at Digestive Disease Week Annual Meeting

Effectiveness and Safety Positively Demonstrated Against Standard of Care; Convenient “Twist and Go” Packaging Unveiled

Aries Pharmaceuticals, Inc. Launches Eleview™ for use in Gastrointestinal Endoscopic Procedures

Novel Development in Submucosal Injection Agents Elevates Lesions to Facilitate Removal

Remimazolam

An ultra-short-acting intravenous benzodiazepine sedative/anesthetic.

Rifamycin SV MMX

A non-absorbable antibiotic for the treatment of bacterial infections of the colon.

LuMeBlue™

novel application of methylene blue to stain the mucosa to discover pre-cancerous lesions and polyps

ELEVIEW™

injectable composition for use in edoscopic removal of adenomas or polyps

Product Manager/Sr. Product Manager

The Product Manager will help shape the commercialization strategy and tactical implementation for the planned 2018 US launch of our first pharmaceutical product within the colorectal cancer market (proprietary Methylene Blue MMX® for detection of pre-cancerous and cancerous lesions and polyps throughout the colon).

Director, Value & Access

The Director of Value & Access will help lead Aries’ creation and implementation of best-in-class Value & Access capabilities leading to access and profit optimization of Aries’ pharmaceutical and device product portfolio.